Stockpiling antiviral flu drugs and vaccines saves lives and reduces disease in a flu pandemic, but is too expensive for around two thirds of the world's population, scientists said on Wednesday.Researchers from Singapore found that stockpiling flu drugs such as Roche's Tamiflu and GlaxoSmithKline's Relenza "significantly reduced" death rates, but said many nations cannot afford to build up stockpiles at current prices. Full story
Related:
Only Rich Countries can Stockpile Drugs - Medindia.net
